BioHarvest Sciences Inc. announced a non-brokered private placement of convertible notes for the gross proceeds of CAD 12,000,000 on October 19, 2023. The notes will have a term of 24 months, and pay interest of 12% per annum. The convertible notes and accrued interest will be convertible at the option of the holder into common shares of the Issuer at a conversion price that is equal to the closing market price of the company?s common shares on the date of conversion less a discount of 20% but in any event, not less than CAD 0.24 per share or more than CAD 0.75 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.235 CAD | -2.08% | -9.62% | +9.30% |
1st Jan change | Capi. | |
---|---|---|
+9.30% | 101M | |
+15.45% | 8.39B | |
+3.59% | 7.58B | |
+15.12% | 6.72B | |
-5.87% | 3.73B | |
+5.27% | 1.44B | |
-30.67% | 1.03B | |
+21.35% | 1.03B | |
-13.58% | 858M | |
-19.00% | 785M |
- Stock Market
- Equities
- BHSC Stock
- News BioHarvest Sciences Inc.
- BioHarvest Sciences Inc. announced that it expects to receive CAD 12 million in funding